Give an account of the molecular genetic defects thatunderlie
thalassaemia and sickle cell disease.
What are the resulting clinical features of these conditions?
Describe the current status and future prospects of ONE of thefollowing
genetic-based treatment options for thesehaemoglobinopathies:
(i) gamma-globin gene reactivation; (ii) gene therapy. (min500words)
